Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity

J Matern Fetal Neonatal Med. 2015 Sep;28(13):1598-601. doi: 10.3109/14767058.2014.962508. Epub 2014 Sep 29.

Abstract

Objective: To determine the practice patterns of antenatal corticosteroid (AS) administration in women with threatened preterm labor.

Methods: This was a retrospective cohort of patients who received betamethasone between 2009 and 2010, identified through a pharmacy database. Patients with high order multiples; incomplete records and indicated preterm delivery were excluded. Demographic and obstetrical factors were compared between women with an AS to delivery latency of ≤7 days versus >7 days. Parametric and non-parametric tests were used as appropriate. p < 0.05 denotes statistical significance; relative risks with 95% confidence intervals were calculated.

Results: Three-hundred forty-five patients were included. Sixty-eight patients (20%) received AS within 7 days of delivery. Women who received AS ≤7 days before delivery (optimal timing) were more likely to have a transvaginal cervical length ≤2 cm (RR:2.53, CI: 1.2-5.6), cervical dilation ≥2 cm (RR: 3.86, CI: 2.7-5.6) and positive fFN (RR: 2.59, CI: 1.1-6.3). Preterm premature ruptured membranes were also associated with optimal timing of AS (RR: 4.86, CI: 3.4-6.8).

Conclusions: Eighty percent of patients receive suboptimal timing of AS administration. Factors associated with suboptimal timing are: cervical length >2 cm, cervical dilation <2 cm and negative fFN. Cervical assessment should be a key factor in the decision for AS administration. More research is needed for accurate timing of AS in women with threatened preterm labor.

Keywords: Antenatal corticosteroids; decision to administer antenatal corticosteroids; timing of antenatal corticosteroids.

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage*
  • Adult
  • Betamethasone / administration & dosage
  • Drug Administration Schedule
  • Female
  • Fetal Organ Maturity* / drug effects
  • Humans
  • Infant, Newborn
  • Lung / drug effects
  • Lung / embryology*
  • Obstetric Labor, Premature / drug therapy*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Pregnancy
  • Retrospective Studies
  • Time Factors
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Betamethasone